Carisma Therapeutics is a startup based in the United States, 3 tracked investors.
Carisma Therapeutics is a company founded in 2018 headquartered in the United States. Brouky records 3 investors associated with the company.
Carisma Therapeutics is a biotechnology company developing CAR-macrophage therapies to treat cancer by fully activating the immune system to recognize and eliminate tumor cells.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.